In addition, carnitine also depletes mitochondrial and ER Ca 2+ storage by activating phospholipase C, further increasing the intracellular Ca 2+ concentration
1.1 Expanded indications and increasing disease prevalence In addition to type 2 diabetes and weight management as key battlegrounds today, GLP-1 therapies have shown clinical promise in treating a wider array of conditions, including Alzheimers disease, cardiovascular risk reduction , MASH (metabolic dysfunction-associated steatohepatitis) and chronic kidney disease (CKD)
Clinical research illustrates an average weight reduction of 15% to 20% when paired with lifestyle modifications, marking it as an exceptional choice among weight loss therapies
Bosch : Id like to start, Mark, by asking you something very basic: If you have to give a two-sentence explanation of Cost Plus Drugs to somebody who just does not understand the bigger issues, how do you do that